Regional Health Properties, Inc.
RHE was delisted on the 3rd of February, 2025.
7 hedge funds and large institutions have $39.2K invested in Regional Health Properties, Inc. in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more funds holding
Funds holding: 7 → 7 (0)
9% less capital invested
Capital invested by funds: $43.2K → $39.2K (-$4.05K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.14K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$41 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$21 |
RHE Hedge Fund Activity: Q3 2024 in Review
7 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Regional Health Properties, Inc. (RHE) for Q3 2024, worth a combined $39.2K — down 9.4% from $43.2K a quarter earlier.
Fund positioning in RHE was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $1.14K. The largest seller was Tower Research Capital (TRC), cutting an estimated $21.
- 7 institutional investors held Regional Health Properties, Inc. (RHE) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $39.2K of Regional Health Properties, Inc. stock for Q3 2024, down 9.4% quarter-over-quarter.
- 0 funds opened new Regional Health Properties, Inc. positions in Q3 2024 and 0 closed out.
- The largest Regional Health Properties, Inc. buyer in Q3 2024 was UBS Group, an estimated $1.14K added.
- The largest Regional Health Properties, Inc. seller in Q3 2024 was Tower Research Capital (TRC), an estimated $21 sold.
Based on aggregated 13F filings for Q3 2024.